Market Overview:
The global human leukocyte antigen (HLA) testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of autoimmune diseases, technological advancements in HLA testing, and rising demand for organ transplants. The molecular assay technologies segment is expected to dominate the global HLA testing market during the forecast period. This segment is projected to grow at a CAGR of 8.0% from 2018 to 2030 due to the increasing demand for accurate and rapid diagnosis of autoimmune diseases.
 Testing Industry Outlook.svg)
Product Definition:
Human leukocyte antigen (HLA) testing is a medical process used to determine a person's human leukocyte antigen (HLA) type. The HLA is a protein found on the surface of white blood cells. There are many different types of HLA, and each one has a specific role in the immune system. The HLA test can be used to help diagnose autoimmune diseases, identify organ donors, and predict how someone will respond to tissue transplants.
Molecular Assay Technologies:
Molecular assay technologies are used for the detection of genetic material from a specific gene or region of DNA. This technology is majorly used in HLA typing, which helps in identifying and classifying an individual's immune response to a particular antigen. The molecular assays are also useful for monitoring the activity of disease-causing genes and determining changes that take place during treatment as well as after recovery from an infection.
Non-molecular Assay Technologies:
Non-molecular assay technologies are used for the detection of HLA antigens in human leukocytes. These techniques include immunoassay methods, Enzyme-linked Immunosorbent Assay (ELISA), and Fluorescent Antibody Identification System (FACIS). The demand for non-molecular assay technologies is increasing due to advantages such as high sensitivity, accuracy, and efficiency over conventional molecular assays.
Application Insights:
The other application segment includes the use of HLA typing in criminal justice, personal identification, and research purposes. The hospital application segment dominated the global market in 2017 owing to an increase in cancer prevalence and rising healthcare expenditure across various regions. According to data published by WHO, it is estimated that around 1.7 million people died from cancer worldwide 2016; this represents approximately 14% of all deaths recorded globally that year.
HLA testing is used for diagnosis of diseases associated with leukocyte infiltration into tissues or organs such as liver disease (hepatitis), lung disease (pulmonary tuberculosis), skin lesions (erythema multiforme) and kidney disease (nephrotic syndrome).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing prevalence of chronic diseases, and high adoption rate for novel technologies. The U.S., which is at the forefront, accounted for more than 80% share in North America owing to its well-developed healthcare infrastructure and growing target population base.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to factors such as improving healthcare facilities & infrastructure; rising awareness about HLA typing; and increasing foreign direct investments by international companies seeking expansion opportunities within this region.
Growth Factors:
- Increasing incidence of autoimmune diseases: The increasing incidence of autoimmune diseases is one of the key growth drivers for the human leukocyte antigen (HLA) testing market. HLA testing helps in early diagnosis and treatment of these diseases, which is expected to boost the demand for HLA tests in the coming years.
- Growing awareness about HLA typing: There is a growing awareness among people about human leukocyte antigen (HLA) typing and its benefits. This is likely to fuel the demand for HLA tests in the coming years.
- Technological advancements: The technological advancements in molecular biology are helping researchers to develop new methods for detecting and classifying human leukocyte antigens (HLAs). This is expected to boost the growth of the global human leukocyte antigen (HLA) testing market in future.
- Rising number of organ transplants: The rising number of organ transplants across globe has led to an increase in demand for human leukocyte antigen (HLA) tests as they are used for tissue matching before transplantation surgeries take place .This factor is anticipated to drivethe growthofhumanleuko cytel antigena(H L A )testingmarketin thenearfuture . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Leukocyte Antigen (HLA) Testing Market Research Report
By Type
Molecular Assay Technologies, Non-molecular Assay Technologies
By Application
Hospital, Research Institute, Other
By Companies
Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson, Hologic, GenDx, Biofortuna
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Human Leukocyte Antigen (HLA) Testing Market Report Segments:
The global Human Leukocyte Antigen (HLA) Testing market is segmented on the basis of:
Types
Molecular Assay Technologies, Non-molecular Assay Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- F. Hoffman-La Roche
- Bio-Rad Laboratories
- QIAGEN N.V.
- Illumina
- Immucor
- CareDx
- Becton Dickinson
- Hologic
- GenDx
- Biofortuna
 Testing Market Overview.svg)
Highlights of The Human Leukocyte Antigen (HLA) Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molecular Assay Technologies
- Non-molecular Assay Technologies
- By Application:
- Hospital
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Leukocyte Antigen (HLA) Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HLA testing is a laboratory test used to determine the specific HLA types of a person's immune system. This information can help doctors better treat that person's medical conditions.
Some of the key players operating in the human leukocyte antigen (hla) testing market are Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson, Hologic, GenDx, Biofortuna.
The human leukocyte antigen (hla) testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Leukocyte Antigen (HLA) Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Leukocyte Antigen (HLA) Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Leukocyte Antigen (HLA) Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Leukocyte Antigen (HLA) Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Leukocyte Antigen (HLA) Testing Market Size & Forecast, 2018-2028
4.5.1 Human Leukocyte Antigen (HLA) Testing Market Size and Y-o-Y Growth
4.5.2 Human Leukocyte Antigen (HLA) Testing Market Absolute $ Opportunity
Chapter 5 Global Human Leukocyte Antigen (HLA) Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Type
5.2.1 Molecular Assay Technologies
5.2.2 Non-molecular Assay Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Human Leukocyte Antigen (HLA) Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Leukocyte Antigen (HLA) Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Human Leukocyte Antigen (HLA) Testing Analysis and Forecast
9.1 Introduction
9.2 North America Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Type
9.6.1 Molecular Assay Technologies
9.6.2 Non-molecular Assay Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Research Institute
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Human Leukocyte Antigen (HLA) Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Type
10.6.1 Molecular Assay Technologies
10.6.2 Non-molecular Assay Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Research Institute
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Human Leukocyte Antigen (HLA) Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Type
11.6.1 Molecular Assay Technologies
11.6.2 Non-molecular Assay Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Research Institute
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Human Leukocyte Antigen (HLA) Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Type
12.6.1 Molecular Assay Technologies
12.6.2 Non-molecular Assay Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Research Institute
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Human Leukocyte Antigen (HLA) Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Type
13.6.1 Molecular Assay Technologies
13.6.2 Non-molecular Assay Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Human Leukocyte Antigen (HLA) Testing Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Research Institute
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Leukocyte Antigen (HLA) Testing Market: Competitive Dashboard
14.2 Global Human Leukocyte Antigen (HLA) Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 F. Hoffman-La Roche
14.3.3 Bio-Rad Laboratories
14.3.4 QIAGEN N.V.
14.3.5 Illumina
14.3.6 Immucor
14.3.7 CareDx
14.3.8 Becton Dickinson
14.3.9 Hologic
14.3.10 GenDx
14.3.11 Biofortuna
